Top FDA Inspection Official to Retire Amid Staff Frustration

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on May 7, 2025.

By I. Edwards HealthDay Reporter

WEDNESDAY, May 7, 2025 — The official in charge of federal food and drug safety inspections will retire May 14.

Michael Rogers, associate commissioner for inspections and investigations at the U.S. Food and Drug Administration (FDA), announced his decision Monday in an email to colleagues.

"I have decided to retire. It was my decision, but it was time after 34 years," Rogers told CBS News in an email.

His departure comes at a time of many concerns within the agency. Some staff members say they are frustrated with the direction of inspections under new FDA Commissioner Dr. Marty Makary.

Rogers led inspection efforts during the 2022 infant formula crisis, when the FDA was criticized for its slow response to problems at an infant formula plant linked to a deadly recall. He also led a reorganization of the inspections office last year, CBS News reported.

Two FDA officials told CBS News that Rogers had recently shared with coworkers that he was unhappy at work. Their comments were made anonymously.

They said that recent staffing cuts ordered by U.S. Health Secretary Robert F. Kennedy Jr. have already made it harder for the inspections team to keep up with demands.

At the same time, Makary has promised to expand surprise foreign inspections. On Monday, he said at a White House event that the FDA would also shorten the length of foreign trips.

"We're also not going to have our inspectors hanging out for three or four weeks," Makary said. "They're going to get in and out, and we're going to do more inspections with the same resources as a result."

But some current and former FDA staff warned these changes could make inspections less effective. In the past, longer trips were seen as a way to group several inspections into one trip, saving money and reducing the strain of traveling.

"So they're going to double or triple the foreign inspection flight costs and keep my people in a perpetual state of jet lag," one FDA official said to CBS News.

Other staff predicted that shorter trips could lead to reduced oversight.

What's more, the FDA has long struggled to reduce a backlog of inspections, especially overseas.

"It's fairly basic math. We know how long inspectional activities take. If they get shorter, which inspections activities are we no longer performing," another FDA official said.

Sources

  • CBS News, May 5, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-05-08 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords